Granules India Limited (GRANULES.NS) NSE

Currency In INR

AD

Granules India Limited

Address

Granules Tower

Hyderabad, TS 500084

India

Phone

91 40 6904 3500

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

4057

First IPO Date

June 20, 2005

Key Executives

NameTitlePayYear Born
Chaitanya TummalaCompany Secretary & Compliance Officer7.89MN/A
Mukesh SuranaChief Financial Officer14.57M1981
Priyanka ChigurupatiHead of Marketing & Executive Director28.36M1989
Uma Devi ChigurupatiNon-Independent Executive Director28.36M1959
Harsha ChigurupatiExecutive Director28.36M1983
Krishna Prasad ChigurupatiChairman & MD283.6M1954
N. BaskaranPresident and Head API Manufacturing & Operations0N/A
Ramraj RangarajaluPresident & Head of Formulations Operations0N/A
Sanjay KumarPresident & Chief Strategy Officer0N/A
Rajesh KapoorPresident & Global Head of Quality0N/A
V. SrinivasChief Technology Officer and Head of R&D01966
AD

Description

Founded in 1984 and headquartered in Hyderabad, India, Granules India Limited operates as a key player in the pharmaceutical sector. The company is engaged in the manufacturing and global distribution of a diverse range of pharmaceutical products, including active pharmaceutical ingredients (APIs), intermediate compounds for drug formulation, and final dosage forms (FDFs). Its API portfolio addresses various therapeutic categories, such as antiviral medications, treatments for hypertension, antihistamines, anti-infectives, pain relief agents, anticoagulants, anti-fibrinolytic drugs, and platelet inhibitors. Additionally, Granules produces a variety of FDFs, encompassing tablets, caplets, and press-fit capsules, which are supplied in bulk, blister packs, and bottles. The firm also develops specialized products for oncology. Granules India Limited maintains a broad international presence, with its products reaching markets across India, North America, Europe, Latin America, Africa, and the Middle East.

AD